Cargando…

NR1I2 genetic polymorphisms and the risk of anti‐tuberculosis drug‐induced hepatotoxicity: A systematic review and meta‐analysis

Anti‐tuberculosis drug‐induced hepatotoxicity (ATDH) is a serious adverse drug reaction. Conflicting results have been obtained regarding the associations of nuclear receptor subfamily 1 group I member 2 (NR1I2) gene polymorphisms on susceptibility to ATDH. Therefore, we aimed to evaluate the associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Miaomiao, Qiu, Yunliang, Jin, Yanyu, Liu, Wenpei, Wang, Qingliang, Yi, Honggang, Tang, Shaowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726956/ https://www.ncbi.nlm.nih.gov/pubmed/33300686 http://dx.doi.org/10.1002/prp2.696

Ejemplares similares

Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity
por: Wu, Shouquan, et al.
Publicado: (2016)

Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study
por: Yang, Miaomiao, et al.
Publicado: (2019)

Genetic polymorphisms of UGT1A1 and susceptibility to anti-tuberculosis drug-induced liver: A RUCAM-based case–control study
por: Tao, Bilin, et al.
Publicado: (2018)

Drug-induced Hepatotoxicity of Anti-tuberculosis Drugs and Their Serum Levels
por: Jeong, Ina, et al.
Publicado: (2015)

Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis
por: Chen, Xinyu, et al.
Publicado: (2023)

Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
por: Heo, Eunyoung, et al.
Publicado: (2017)

Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis
por: Saito, Zenya, et al.
Publicado: (2016)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity
por: Sharma, Surendra K., et al.
Publicado: (2016)

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis
por: Zhang, Haiping, et al.
Publicado: (2019)

Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
por: Molla, Yalew, et al.
Publicado: (2021)

Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study
por: Chen, Shixian, et al.
Publicado: (2019)

Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis
por: Wang, Nannan, et al.
Publicado: (2022)

A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity
por: Huang, Tao, et al.
Publicado: (2016)

The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study
por: Song, Jin Hwa, et al.
Publicado: (2019)

GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients
por: Jaramillo-Valverde, Luis, et al.
Publicado: (2022)

Anti-Tuberculosis Treatment: Induced Hepatotoxicity – A Case Report
por: Kumar, Poludasari Shravan, et al.
Publicado: (2020)

Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
por: Wang, Yu, et al.
Publicado: (2019)

Ketogenic Diet and Drug-Induced Hepatotoxicity During Tuberculosis Treatment
por: Branco Caetano, Francisco, et al.
Publicado: (2022)

The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial
por: Talebi, Ali, et al.
Publicado: (2023)

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
por: Lomtadze, Nino, et al.
Publicado: (2013)

NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in Bandung, Indonesia
por: Headriawan, Achmad, et al.
Publicado: (2021)

First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
por: Bouazzi, Omaima El, et al.
Publicado: (2016)

Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort
por: Tang, Shaowen, et al.
Publicado: (2013)

Association of NR1I2 gene polymorphisms and time of progression to AIDS
por: de Medeiros, Rúbia Marília, et al.
Publicado: (2017)

Drug-Induced Hepatotoxicity: Metabolic, Genetic and Immunological Basis
por: Njoku, Dolores B.
Publicado: (2014)

Impact of Glutathione S-Transferase M1 and T1 on Anti-Tuberculosis Drug–Induced Hepatotoxicity in Chinese Pediatric Patients
por: Liu, Fang, et al.
Publicado: (2014)

Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs
por: El-Jaick, Kenia Balbi, et al.
Publicado: (2022)

Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients
por: Yagishita, Hironobu, et al.
Publicado: (2022)

iNR-Drug: Predicting the Interaction of Drugs with Nuclear Receptors in Cellular Networking
por: Fan, Yue-Nong, et al.
Publicado: (2014)

Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort
por: Chen, Ru, et al.
Publicado: (2016)

Genetic Polymorphisms of IFNG and IFNGR1 with Latent Tuberculosis Infection
por: Wu, Shouquan, et al.
Publicado: (2019)

Analysis of IL-6, STAT3 and HSPA1L Gene Polymorphisms in Anti-Tuberculosis Drug-Induced Hepatitis in a Nested Case-Control Study
por: Wang, Jing, et al.
Publicado: (2015)

Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients
por: Yimer, Getnet, et al.
Publicado: (2008)

Fine mapping of genetic polymorphisms of pulmonary tuberculosis within chromosome 18q11.2 in the Chinese population: a case-control study
por: Dai, Yaoyao, et al.
Publicado: (2011)

Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved
por: Martínez-Sena, Teresa, et al.
Publicado: (2023)

Host genetics and tuberculosis: Theory of genetic polymorphism and tuberculosis
por: Aravindan, PP
Publicado: (2019)

Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST
por: Santos, Eliana Abreu, et al.
Publicado: (2019)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory Agents
por: Chen, Zhipeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tpjvogjtr58ovrrefh9hojqqgr